Crescent Capital BDC (NASDAQ:CCAP) Trading Down 3.5% - What's Next?

Crescent Capital BDC, Inc. (NASDAQ:CCAP - Get Free Report) fell 3.5% during trading on Monday . The company traded as low as $14.30 and last traded at $14.28. 177,865 shares traded hands during mid-day trading, an increase of 27% from the average session volume of 140,008 shares. The stock had previously closed at $14.80.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on CCAP shares. Wall Street Zen downgraded shares of Crescent Capital BDC from a "hold" rating to a "sell" rating in a report on Thursday, May 22nd. Raymond James dropped their target price on shares of Crescent Capital BDC from $20.00 to $17.00 and set an "outperform" rating on the stock in a research report on Friday, May 16th. Keefe, Bruyette & Woods lowered Crescent Capital BDC from an "outperform" rating to a "market perform" rating and reduced their target price for the company from $18.50 to $17.00 in a report on Friday, May 16th. Finally, Wells Fargo & Company dropped their price target on Crescent Capital BDC from $16.00 to $15.00 and set an "equal weight" rating on the stock in a report on Friday, May 16th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, Crescent Capital BDC has an average rating of "Hold" and a consensus price target of $17.60.

Crescent Capital BDC Price Performance

The firm has a 50 day moving average price of $15.45 and a two-hundred day moving average price of $17.58. The company has a market cap of $531.07 million, a P/E ratio of 7.20 and a beta of 0.55. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.26 and a current ratio of 1.32.

Crescent Capital BDC (NASDAQ:CCAP - Get Free Report) last posted its earnings results on Wednesday, May 14th. The company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.52 by ($0.07). The business had revenue of $42.13 million during the quarter, compared to analysts' expectations of $45.08 million. Crescent Capital BDC had a return on equity of 11.90% and a net margin of 37.32%. On average, analysts predict that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.

Crescent Capital BDC Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Monday, June 30th will be given a $0.42 dividend. This represents a $1.68 annualized dividend and a dividend yield of 11.72%. The ex-dividend date of this dividend is Monday, June 30th. Crescent Capital BDC's dividend payout ratio (DPR) is presently 125.37%.

Institutional Trading of Crescent Capital BDC

A number of institutional investors have recently added to or reduced their stakes in the stock. Montag A & Associates Inc. bought a new stake in shares of Crescent Capital BDC during the fourth quarter valued at about $35,000. C M Bidwell & Associates Ltd. bought a new position in Crescent Capital BDC in the 4th quarter valued at $39,000. Aquatic Capital Management LLC purchased a new position in shares of Crescent Capital BDC during the 4th quarter valued at $129,000. Generation Capital Management LLC bought a new position in shares of Crescent Capital BDC in the fourth quarter worth $192,000. Finally, First Affirmative Financial Network purchased a new stake in shares of Crescent Capital BDC in the first quarter worth $199,000. Hedge funds and other institutional investors own 49.46% of the company's stock.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.